These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 33998164)

  • 1. Impairment of the ER/mitochondria compartment in human cardiomyocytes with PLN p.Arg14del mutation.
    Cuello F; Knaust AE; Saleem U; Loos M; Raabe J; Mosqueira D; Laufer S; Schweizer M; van der Kraak P; Flenner F; Ulmer BM; Braren I; Yin X; Theofilatos K; Ruiz-Orera J; Patone G; Klampe B; Schulze T; Piasecki A; Pinto Y; Vink A; Hübner N; Harding S; Mayr M; Denning C; Eschenhagen T; Hansen A
    EMBO Mol Med; 2021 Jun; 13(6):e13074. PubMed ID: 33998164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the PLN p.Arg14del Mutation in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
    Badone B; Ronchi C; Lodola F; Knaust AE; Hansen A; Eschenhagen T; Zaza A
    Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phospholamban immunostaining is a highly sensitive and specific method for diagnosing phospholamban p.Arg14del cardiomyopathy.
    Te Rijdt WP; van der Klooster ZJ; Hoorntje ET; Jongbloed JDH; van der Zwaag PA; Asselbergs FW; Dooijes D; de Boer RA; van Tintelen JP; van den Berg MP; Vink A; Suurmeijer AJH
    Cardiovasc Pathol; 2017; 30():23-26. PubMed ID: 28759816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DWORF Extends Life Span in a PLN-R14del Cardiomyopathy Mouse Model by Reducing Abnormal Sarcoplasmic Reticulum Clusters.
    Stege NM; Eijgenraam TR; Oliveira Nunes Teixeira V; Feringa AM; Schouten EM; Kuster DWD; van der Velden J; Wolters AHG; Giepmans BNG; Makarewich CA; Bassel-Duby R; Olson EN; de Boer RA; Silljé HHW
    Circ Res; 2023 Dec; 133(12):1006-1021. PubMed ID: 37955153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phospholamban p.Arg14del cardiomyopathy is characterized by phospholamban aggregates, aggresomes, and autophagic degradation.
    Te Rijdt WP; van Tintelen JP; Vink A; van der Wal AC; de Boer RA; van den Berg MP; Suurmeijer AJ
    Histopathology; 2016 Oct; 69(4):542-50. PubMed ID: 26970417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional and transcriptomic insights into pathogenesis of R9C phospholamban mutation using human induced pluripotent stem cell-derived cardiomyocytes.
    Ceholski DK; Turnbull IC; Kong CW; Koplev S; Mayourian J; Gorski PA; Stillitano F; Skodras AA; Nonnenmacher M; Cohen N; Björkegren JLM; Stroik DR; Cornea RL; Thomas DD; Li RA; Costa KD; Hajjar RJ
    J Mol Cell Cardiol; 2018 Jun; 119():147-154. PubMed ID: 29752948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computer versus cardiologist: Is a machine learning algorithm able to outperform an expert in diagnosing a phospholamban p.Arg14del mutation on the electrocardiogram?
    Bleijendaal H; Ramos LA; Lopes RR; Verstraelen TE; Baalman SWE; Oudkerk Pool MD; Tjong FVY; Melgarejo-Meseguer FM; Gimeno-Blanes FJ; Gimeno-Blanes JR; Amin AS; Winter MM; Marquering HA; Kok WEM; Zwinderman AH; Wilde AAM; Pinto YM
    Heart Rhythm; 2021 Jan; 18(1):79-87. PubMed ID: 32911053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ranolazine rescues the heart failure phenotype of PLN-deficient human pluripotent stem cell-derived cardiomyocytes.
    Jiang Y; Li X; Guo T; Lu WJ; Ma S; Chang Y; Song Y; Zhang S; Bai R; Wang H; Qi M; Jiang H; Zhang H; Lan F
    Stem Cell Reports; 2022 Apr; 17(4):804-819. PubMed ID: 35334215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The phospholamban p.(Arg14del) pathogenic variant leads to cardiomyopathy with heart failure and is unreponsive to standard heart failure therapy.
    Eijgenraam TR; Boukens BJ; Boogerd CJ; Schouten EM; van de Kolk CWA; Stege NM; Te Rijdt WP; Hoorntje ET; van der Zwaag PA; van Rooij E; van Tintelen JP; van den Berg MP; van der Meer P; van der Velden J; Silljé HHW; de Boer RA
    Sci Rep; 2020 Jun; 10(1):9819. PubMed ID: 32555305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High resolution systematic digital histological quantification of cardiac fibrosis and adipose tissue in phospholamban p.Arg14del mutation associated cardiomyopathy.
    Gho JM; van Es R; Stathonikos N; Harakalova M; te Rijdt WP; Suurmeijer AJ; van der Heijden JF; de Jonge N; Chamuleau SA; de Weger RA; Asselbergs FW; Vink A
    PLoS One; 2014; 9(4):e94820. PubMed ID: 24732829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein Aggregation Is an Early Manifestation of Phospholamban p.(Arg14del)-Related Cardiomyopathy: Development of PLN-R14del-Related Cardiomyopathy.
    Eijgenraam TR; Boogerd CJ; Stege NM; Oliveira Nunes Teixeira V; Dokter MM; Schmidt LE; Yin X; Theofilatos K; Mayr M; van der Meer P; van Rooij E; van der Velden J; Silljé HHW; de Boer RA
    Circ Heart Fail; 2021 Nov; 14(11):e008532. PubMed ID: 34587756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel human R25C-phospholamban mutation is associated with super-inhibition of calcium cycling and ventricular arrhythmia.
    Liu GS; Morales A; Vafiadaki E; Lam CK; Cai WF; Haghighi K; Adly G; Hershberger RE; Kranias EG
    Cardiovasc Res; 2015 Jul; 107(1):164-74. PubMed ID: 25852082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phospholamban ablation rescues sarcoplasmic reticulum Ca(2+) handling but exacerbates cardiac dysfunction in CaMKIIdelta(C) transgenic mice.
    Zhang T; Guo T; Mishra S; Dalton ND; Kranias EG; Peterson KL; Bers DM; Brown JH
    Circ Res; 2010 Feb; 106(2):354-62. PubMed ID: 19959778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of Protein Phosphatase 1 Regulatory Subunit PPP1R3A Promotes Atrial Fibrillation.
    Alsina KM; Hulsurkar M; Brandenburg S; Kownatzki-Danger D; Lenz C; Urlaub H; Abu-Taha I; Kamler M; Chiang DY; Lahiri SK; Reynolds JO; Quick AP; Scott L; Word TA; Gelves MD; Heck AJR; Li N; Dobrev D; Lehnart SE; Wehrens XHT
    Circulation; 2019 Aug; 140(8):681-693. PubMed ID: 31185731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leducq Transatlantic Network of Excellence to Cure Phospholamban-Induced Cardiomyopathy (CURE-PLaN).
    Doevendans PA; Glijnis PC; Kranias EG
    Circ Res; 2019 Sep; 125(7):720-724. PubMed ID: 31513489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HNO enhances SERCA2a activity and cardiomyocyte function by promoting redox-dependent phospholamban oligomerization.
    Sivakumaran V; Stanley BA; Tocchetti CG; Ballin JD; Caceres V; Zhou L; Keceli G; Rainer PP; Lee DI; Huke S; Ziolo MT; Kranias EG; Toscano JP; Wilson GM; O'Rourke B; Kass DA; Mahaney JE; Paolocci N
    Antioxid Redox Signal; 2013 Oct; 19(11):1185-97. PubMed ID: 23919584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of Skeletal Muscle Biopsy and Derived Myoblasts in a Patient Carrying Arg14del Mutation in
    Zanotti S; Ripolone M; Napoli L; Velardo D; Salani S; Ciscato P; Priori S; Kukavica D; Mazzanti A; Diamanti L; Vegezzi E; Moggio M; Corti S; Comi G; Sciacco M
    Cells; 2023 May; 12(10):. PubMed ID: 37408239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antisense Therapy Attenuates Phospholamban p.(Arg14del) Cardiomyopathy in Mice and Reverses Protein Aggregation.
    Eijgenraam TR; Stege NM; Oliveira Nunes Teixeira V; de Brouwer R; Schouten EM; Grote Beverborg N; Sun L; Später D; Knöll R; Hansson KM; Amilon C; Janzén D; Yeh ST; Mullick AE; van der Meer P; de Boer RA; Silljé HHW
    Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrent and founder mutations in the Netherlands-Phospholamban p.Arg14del mutation causes arrhythmogenic cardiomyopathy.
    van der Zwaag PA; van Rijsingen IA; de Ruiter R; Nannenberg EA; Groeneweg JA; Post JG; Hauer RN; van Gelder IC; van den Berg MP; van der Harst P; Wilde AA; van Tintelen JP
    Neth Heart J; 2013 Jun; 21(6):286-93. PubMed ID: 23568436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deletion of DWORF does not affect cardiac function in aging and in PLN-R14del cardiomyopathy.
    Stege NM; Oliveira Nunes Teixeira V; Zijlstra SN; Feringa AM; de Boer RA; Silljé HHW
    Am J Physiol Heart Circ Physiol; 2024 Mar; 326(3):H870-H876. PubMed ID: 38334971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.